“The virus does not have high variability, that’s absolutely ... It’s even impossible to compare it with the flu virus today. Another thing is that even those few tens of mutations that are described today, and this is normal for any microorganism, cannot be assessed in terms of the effect on the change in the capabilities of this virus - to affect people, cause serious or not serious diseases, ”the head of the department said.
Popova explained that all countries that can sequence the virus publish the results in information systems, and analysis of such systems shows that the virus does not show high levels of mutations.
Earlier, Popova said that if there is no production opportunity to create immediately a large volume of the vaccine against coronavirus, vaccination will begin in the first place at risk.